INDEXING mItts : 1,2-dioxetane . 13-galactosidase . 13-glucuronidase #{149} luciferase #{149} alkaline phosphatase #{149} multianalyte assays Chemiluminescent l,2-dioxetane enzyme substrates [1, 2] are now widely used in clinical immunoassays [3, 4] . These chemi- [5, 6] , including those encoding chloramphenicol acetyltransferase (CAT) [7] , /3-galactosidase (/3-Gal) [8] , /3-glucuronidase (GUS) [9, 10] ,luciferase [11, 12] ,placental alkaline phosphatase [13] ,human growth hormone (hGH) [14] , and aequorin [151.1 Because two of the reporter gene proteins, secreted placental alkaline phosphatase (SEAP) [13, 16] and hGH, are secreted from cells and measured directly from the culture medium, the assay format is very simple and is particularly beneficial for pharmaceutical screening applications [17] .
Afterintroductionof a reporter gene constructintocells, the amount of reporter gene protein expressed can be measured in a sample of cell extract or culture medium by various analytical techniques, including radioisotopic, colorimetric, fluorescence, chemiluminescence, and immunodetection methods [5] . Isotopic detection methods (for CAT and hGH reporter proteins) pose a biohazard and are limited by high cost, poor sensitivity, and narrow dynamic range [5, 18] .Colorimetric detection (/3-Gal and SEAP) generally has low sensitivity [8, 13] . Fluorescence methods (/3-Gal and GUS) are often limited by the presence of a high amount of autofluorescence and are subject to quenching by high amounts of protein [19] . Immunoassay detection (/3-Gal, CAT, and hGH) is labor intensive and has low sensitivity.
In contrast, luminescence assay methods (/3-Gal, GUS, SEAP, luciferase, and aequorin) provide high sensitivity, a wide dynamic assay range, and simple assay formats [5, 8, 18, 20, 21] .
We have developed a series of l,2-dioxetane enzyme substrates (Galactonr and Galacton-Plus' for /3-Gal, Glucuron''
for GUS, and CSPD#{174} for alkaline phosphatase) and incorporated them into assays, Galacto-Light'' [20] , GUS-Light" [20, 21] , and Phospha-Light' [20, 21] chemiluminescence reporter gene assay systems, respectively. The Galacton-Plus substrate is also included in the Dual-Light' [22] reporter gene assay system for detecting both /3-Gal and luciferase activities in a single-tube assay. In the presence of these enhancer reagents, which include Emerald"
and Sapphire-Il"", the signal is enhanced by -100-to 1000-fold [23] . Luminescence reporter gene assays are ideally performed with a luminometer for maximum sensitivity, but the luminescence can also be measured with a scintillation counter [24, 25] . Here, we describe the experimental protocols and present the results obtained with these luminescence assay systems incorporating 1,2-dioxetane substrates for detecting /3-Gal, SEAP, and a dual assay for /3-Gal and luciferase reporter enzymes.
Matenals and Methods

REAGENTS AND INSTRUMENTATION
Purified human placental alkaline phosphatase (P-3895; EC 3. 
Resultsand Discussion
Serial dilutions
of purified /3-Gal, placental alkaline phosphatase, and luciferase were assayed, and the detection limits obtained for each enzyme by the chemiluminescent reporter gene assay are shown in Table 1 . These results significantly advanced the level of detection compared with other methodologies. The detection limit for /3-Gal obtained with GalactonPlus substrate (0.008 pg, Fig. 1 ) is much lower than the published detection limits: 100 pg with a colorimetric substrate, 2 pg with a fluorescent substrate [8] . With both chemiluminescence /3-Gal substrates, the dynamic range exceeds five orders of magnitude ( Fig. 1 ) [20] . An important benefit of the Galacton-Plus substrate is the prolonged light-emission kinetics.
With Galacton-Plus, the signal intensity remains constant for -1 h after addition of the light-emission accelerator [20] . The longer-lived signal allows the use of a variety of instruments, particularly luminometers and scintillation counters without injectors. Both /3-Gal assays use reaction buffers at pH 8, which allows discrimination between the bacterial reporter enzyme and the endogenous [8] . In addition, Glucuron substrate allows detection of as little as 60 fg of purified GUS, and the linear assay range extends from 10_mi to iO g of enzyme [21] . Measurement of SEAP differs from that of /3-Gal in that the former is detected directly in an aliquot of culture supernate, leaving the cells intact for further experimentation.
In addition, the SEAP assay exhibits glow-type emission kinetics [20, 21] , 50 this enzyme can be measured in luminometers without injection devices or scintillation counters. With CSPD substrate, one can detect 0.03 3 pg of purified human placental alkaline phosphatase, as much as 1000-fold less than that reported for the colorimetric substrate, p-nitrophenyl phosphate (10 pg) [5] . The dynamic range of measurement covers five orders of magnitude of enzyme concentration (Fig. 2) . Because placental alkaline phosphatase is thermally stable, a simple heat treatment mactiyates any nonplacental alkaline phosphatase isoenzymes present in the samples [13, 21] . L-Homoarginine further inhibits nonplacental enzyme activity [13, 21] .
The ability to detect both luciferase and /3-Gal activity in a single extract aliquot is a unique feature of the Dual-Light assay system. The assay system was designed to be more convenient without sacrificing the sensitivity of the individual assays and to reduce pipetting errors. The system combines an enhanced luciferase reaction (measured immediately)
with the GalactonPlus reaction (measured 15-60 mm later, immediately after the injection of Accelerator-lI).
The detection limit for the luciferase reaction component of the Dual-Light assay system (2 fg of luciferase) is comparable with that obtained with a single luciferase assay. The detection limit for /3-Gal (0.008 pg) assayed with Galacton-Plus is similar in both the individual and the dual-enzyme detection systems [22] . The Dual-Light reporter gene assay system for quantifying both /3-Gal and luciferase activity can be used either as a convenient assay for simultaneous transfection normalization and experimental determination or to multiplex experimental reporter gene assays to increase screening efficiency. In conclusion, the assays described are model assays for sensitive detection of reporter gene products. Cell-based reporter gene assays are valuable screening methods for identifying small molecules that can alter the activity of transcription factors and affect gene regulation. Transcription factors and gene expression are important targets in drug discovery efforts for important clinical conditions such as viral infection, cancer, inflammation, immune dysfunction, and hormone response.
Chemiluminescent reporter gene assays provide highly sensitive detection with simple assay formats that are amenable to automation with a broad range of instrumentation for highthroughput compound screening.
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